Literature DB >> 23575982

Difficult-to-treat asthma in childhood.

Alexandra Adams1, Sejal Saglani.   

Abstract

Asthma continues to be one of the greatest burdens to healthcare resources throughout the developed world. In most cases, good symptom control can be achieved with low-dose inhaled corticosteroids, and can be cared for in the primary and secondary healthcare systems. However, there is a group in whom control is not achieved despite high-dose inhaled corticosteroids and maximal add-on therapies; these are children with problematic severe asthma that should be referred to a specialist team for further investigation and management. In this review we aimed to provide an evidence-based guide for pediatricians providing care for children with asthma in secondary healthcare settings. The review focuses on a proposed investigation and management strategy for children aged between 6 and 16 years with problematic severe asthma, and is supported as far as possible by evidence from the literature. We first address recent advances in nomenclature and then discuss our proposed course of investigation and management of these children. Distinction of children with true, severe, therapy-resistant asthma from those with asthma that is difficult to treat because of unaddressed underlying modifiable factors is critical and is discussed in detail.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23575982     DOI: 10.1007/s40272-013-0025-5

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  48 in total

1.  Asthma Control Questionnaire in children: validation, measurement properties, interpretation.

Authors:  E F Juniper; K Gruffydd-Jones; S Ward; K Svensson
Journal:  Eur Respir J       Date:  2010-06-07       Impact factor: 16.671

Review 2.  Management of severe asthma in children.

Authors:  Andrew Bush; Sejal Saglani
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

3.  T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma.

Authors:  Wisam Al-Ramli; David Préfontaine; Fazila Chouiali; James G Martin; Ron Olivenstein; Catherine Lemière; Qutayba Hamid
Journal:  J Allergy Clin Immunol       Date:  2009-04-10       Impact factor: 10.793

Review 4.  Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where?

Authors:  A Bush; S Pedersen; G Hedlin; E Baraldi; A Barbato; F de Benedictis; K C Lødrup Carlsen; J de Jongste; G Piacentini
Journal:  Eur Respir J       Date:  2011-07-07       Impact factor: 16.671

Review 5.  Evidence for phenotype-driven treatment in asthmatic patients.

Authors:  Sherif Gonem; Dhananjay Desai; Salman Siddiqui; Christopher C E Brightling
Journal:  Curr Opin Allergy Clin Immunol       Date:  2011-08

Review 6.  Anti-interleukin-5 antibody therapy in asthma and allergies.

Authors:  Jonathan Corren
Journal:  Curr Opin Allergy Clin Immunol       Date:  2011-12

7.  Resolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17-producing {gamma}{delta}T cells.

Authors:  Jenna R Murdoch; Clare M Lloyd
Journal:  Am J Respir Crit Care Med       Date:  2010-04-22       Impact factor: 21.405

Review 8.  Phenotype-specific treatment of difficult asthma in children.

Authors:  Donald Payne; Andrew Bush
Journal:  Paediatr Respir Rev       Date:  2004-06       Impact factor: 2.726

9.  The prevalence of nonadherence in difficult asthma.

Authors:  Jacqueline Gamble; Michael Stevenson; Elizabeth McClean; Liam G Heaney
Journal:  Am J Respir Crit Care Med       Date:  2009-07-30       Impact factor: 21.405

Review 10.  Steroid resistance in asthma: our current understanding.

Authors:  A K Kamada; D Y Leung; S J Szefler
Journal:  Pediatr Pulmonol       Date:  1992-11
View more
  4 in total

1.  Triptolide inhibits TGF-β1 induced proliferation and migration of rat airway smooth muscle cells by suppressing NF-κB but not ERK1/2.

Authors:  Ming Chen; Jian-Ting Shi; Zhi-Qiang Lv; Lin-Jie Huang; Xiao-Ling Lin; Wei Zhang; Rui-Yun Liang; Yi-Qun Li; Shan-Ping Jiang
Journal:  Immunology       Date:  2014-09-29       Impact factor: 7.397

2.  Apigenin inhibits TGF-β1-induced proliferation and migration of airway smooth muscle cells.

Authors:  Li-Hua Li; Bin Lu; Hong-Ke Wu; Hao Zhang; Fei-Fei Yao
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 3.  Difficult and Severe Asthma in Children.

Authors:  Federica Porcaro; Nicola Ullmann; Annalisa Allegorico; Antonio Di Marco; Renato Cutrera
Journal:  Children (Basel)       Date:  2020-12-10

4.  Integrated traditional Chinese medicine for childhood asthma in Taiwan: a Nationwide cohort study.

Authors:  Yu-Chiang Hung; I-Ling Hung; Mao-Feng Sun; Chih-Hsin Muo; Bei-Yu Wu; Ying-Jung Tseng; Wen-Long Hu
Journal:  BMC Complement Altern Med       Date:  2014-10-10       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.